Clinical trial
A 26-week, Multicenter, Controlled Trial of the Glycemic Outcomes of Individualized Treatment Support in Patients With Type 2 Diabetes
NCT03258268 is registered in ClinicalTrials.gov with Läkarexpressen AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 26-week, Multicenter, Controlled Trial of the Glycemic Outcomes of Individualized Treatment Support in Patients With Type 2 Diabetes
- Lead sponsor
- Läkarexpressen AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 7, 2017
- Completion date
- December 19, 2019
- Enrollment
- 311 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus